Searchable abstracts of presentations at key conferences in endocrinology

ea0029p510 | Diabetes | ICEECE2012

The redution hypothalamic PP2A expression improve peripheral insulin sensitivity

Picardi P. , Caldeira E. , Caricilli A. , Saad M.

Protein phosphatase 2A (PP2A) is a multimeric serine/threonine phosphatase which has multiple functions. However, the potential involvement of PP2A in insulin’s metabolic signaling pathway is presently unknown. Brain insulin resistant state is characterized by disturbances in transducing the signal from IR/IRS/AKT, changing feeding behaviour and body weight. We showed that diet induced obese rats (DIO) have a marked increase in PP2A protein expression in the hypothalamus....

ea0029p1105 | Neuroendocrinology | ICEECE2012

Topiramate treatment improves hypothalamic insulin and leptin signaling and action and reduces obesity in mice

Caricilli A. , Penteado , Mittestainer F. , Abreu L. , Quaresma P. , Santos A. , Guadagnini D. , Razolli D. , Velloso L. , Saad M. , Prada P.

Topiramate (TPM) is an anticonvulsant drug used for the treatment of epilepsy and prophylaxis of migraine. Weight loss is a side effect frequently reported in patients and animal models treated with TPM. Some studies showed that TPM may decrease energy storage, and thus increase energy expenditure and thermogenesis. However, the mechanisms by which TPM reduces body weight are not completely understood. Anorexigenic hormones such as insulin and leptin regulate the activity of d...